The study of more than 3,127 adults found that it reduced weight by an average of 27.3 pounds (12.4%) among people who had obesity or overweight with at least one weight-related medical problem such as hypertension, who did not have diabetes, and who were using the highest dose of the medication, the company said in a news release
With its dual focus on appetite control and metabolic health, semaglutide offers a fresh, science-backed approach to achieving and maintaining a healthier weight
The clinical model is the differentiator: proactive, clinician-initiated dose titration and unlimited messaging, with a menopause and clinical-support framing that suits readers who want a coordinated program
legal supply chain
official who now leads the Center for Science in the Public Interest, told me
Kimble R, Keane KM, Lodge JK, Cheung W, Haskell-Ramsay CF, Howatson G